FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173120935> ?p ?o ?g. }

• W3173120935 abstract "Abstract Background To increase locoregional and systemic tumor control, a portion of patients with stage III (N2, N3) non-small cell lung cancer (NSCLC) received pulmonary resection after immunochemotherapy in our center. Herein, we assessed the real-world downstage (T, N stage) effectiveness of immunochemotherapy as induction treatment and explored the proper cycle number for stage III (N2, N3) NSCLC. Methods Biopsy confirmed stage III (N2, N3) NSCLC patients who underwent immunochemotherapy between January 1 st, 2018, to August 30 th, 2019, were identified. Tumor radiologic regression, lymph node down-staging, and pathological response information were collected. Results In total, 16 patients with stage IIIA NSCLC, 30 with stage IIIB NSCLC, 9 with stage IIIC NSCLC (N2, N3 metastasis) were included. After immunochemotherapy, 25/55 (45.5%) patients achieved an objective response. Ultimately, 33/55 (60.0%) patients received lobectomy plus systemic lymphadenectomy, of whom 18/33 (54.5%) obtained major pathological response (MPR) of the primary lesion, and 24 (72.7%) had pathological-confirmed lymph node downstage (N2-3 to N0-1). Notably, four patients had MPR of the primary lesion but without lymph node downstage. At the time of data cutoff (December 30 th, 2020), the median follow-up duration was 9.2 months (IQR 8.0-11.7), 24/33 (72.7%) of patients that had pulmonary resection were progression-free, with 30 of them alive. Binary logistics analysis showed that 3-4 induction cycles were favorably associated with MPR than 1-2 cycles (p = 0.017). Conclusions Immunochemotherapy as induction treatment showed encouraging MPR and lymph nodes down-staging rates in stage III (N2, N3) NSCLC in this study. Prolonged (3-4) cycles of immunochemotherapy were recommended for a better pathological response." @default.
• W3173120935 created "2021-06-22" @default.
• W3173120935 creator A5004809139 @default.
• W3173120935 creator A5006701727 @default.
• W3173120935 creator A5007865984 @default.
• W3173120935 creator A5008749330 @default.
• W3173120935 creator A5022473329 @default.
• W3173120935 creator A5031082896 @default.
• W3173120935 creator A5031255136 @default.
• W3173120935 creator A5052883326 @default.
• W3173120935 creator A5059667364 @default.
• W3173120935 creator A5063112148 @default.
• W3173120935 creator A5074447759 @default.
• W3173120935 creator A5080123424 @default.
• W3173120935 date "2021-06-05" @default.
• W3173120935 modified "2023-10-16" @default.
• W3173120935 title "Immunochemotherapy as induction treatment in Stage III (N2, N3) Non-small cell lung cancer" @default.
• W3173120935 cites W1968899146 @default.
• W3173120935 cites W1988160404 @default.
• W3173120935 cites W2019607817 @default.
• W3173120935 cites W2104701073 @default.
• W3173120935 cites W2228221433 @default.
• W3173120935 cites W2521503673 @default.
• W3173120935 cites W2545977562 @default.
• W3173120935 cites W2749232358 @default.
• W3173120935 cites W2762777471 @default.
• W3173120935 cites W2791043965 @default.
• W3173120935 cites W2798160602 @default.
• W3173120935 cites W2890732752 @default.
• W3173120935 cites W2898551321 @default.
• W3173120935 cites W2905289065 @default.
• W3173120935 cites W2947111267 @default.
• W3173120935 cites W2991240940 @default.
• W3173120935 cites W2992931937 @default.
• W3173120935 cites W3005124847 @default.
• W3173120935 cites W3021010739 @default.
• W3173120935 cites W3086555948 @default.
• W3173120935 cites W3089266118 @default.
• W3173120935 cites W3091695757 @default.
• W3173120935 cites W3094192068 @default.
• W3173120935 cites W3124196524 @default.
• W3173120935 doi "https://doi.org/10.1101/2021.06.03.21257757" @default.
• W3173120935 hasPublicationYear "2021" @default.
• W3173120935 type Work @default.
• W3173120935 sameAs 3173120935 @default.
• W3173120935 citedByCount "0" @default.
• W3173120935 crossrefType "posted-content" @default.
• W3173120935 hasAuthorship W3173120935A5004809139 @default.
• W3173120935 hasAuthorship W3173120935A5006701727 @default.
• W3173120935 hasAuthorship W3173120935A5007865984 @default.
• W3173120935 hasAuthorship W3173120935A5008749330 @default.
• W3173120935 hasAuthorship W3173120935A5022473329 @default.
• W3173120935 hasAuthorship W3173120935A5031082896 @default.
• W3173120935 hasAuthorship W3173120935A5031255136 @default.
• W3173120935 hasAuthorship W3173120935A5052883326 @default.
• W3173120935 hasAuthorship W3173120935A5059667364 @default.
• W3173120935 hasAuthorship W3173120935A5063112148 @default.
• W3173120935 hasAuthorship W3173120935A5074447759 @default.
• W3173120935 hasAuthorship W3173120935A5080123424 @default.
• W3173120935 hasBestOaLocation W31731209351 @default.
• W3173120935 hasConcept C121608353 @default.
• W3173120935 hasConcept C126322002 @default.
• W3173120935 hasConcept C141071460 @default.
• W3173120935 hasConcept C143998085 @default.
• W3173120935 hasConcept C146357865 @default.
• W3173120935 hasConcept C151730666 @default.
• W3173120935 hasConcept C207886595 @default.
• W3173120935 hasConcept C2775934546 @default.
• W3173120935 hasConcept C2776256026 @default.
• W3173120935 hasConcept C2779013556 @default.
• W3173120935 hasConcept C2780283643 @default.
• W3173120935 hasConcept C2780824555 @default.
• W3173120935 hasConcept C2780849966 @default.
• W3173120935 hasConcept C71924100 @default.
• W3173120935 hasConcept C86803240 @default.
• W3173120935 hasConcept C90924648 @default.
• W3173120935 hasConceptScore W3173120935C121608353 @default.
• W3173120935 hasConceptScore W3173120935C126322002 @default.
• W3173120935 hasConceptScore W3173120935C141071460 @default.
• W3173120935 hasConceptScore W3173120935C143998085 @default.
• W3173120935 hasConceptScore W3173120935C146357865 @default.
• W3173120935 hasConceptScore W3173120935C151730666 @default.
• W3173120935 hasConceptScore W3173120935C207886595 @default.
• W3173120935 hasConceptScore W3173120935C2775934546 @default.
• W3173120935 hasConceptScore W3173120935C2776256026 @default.
• W3173120935 hasConceptScore W3173120935C2779013556 @default.
• W3173120935 hasConceptScore W3173120935C2780283643 @default.
• W3173120935 hasConceptScore W3173120935C2780824555 @default.
• W3173120935 hasConceptScore W3173120935C2780849966 @default.
• W3173120935 hasConceptScore W3173120935C71924100 @default.
• W3173120935 hasConceptScore W3173120935C86803240 @default.
• W3173120935 hasConceptScore W3173120935C90924648 @default.
• W3173120935 hasLocation W31731209351 @default.
• W3173120935 hasOpenAccess W3173120935 @default.
• W3173120935 hasPrimaryLocation W31731209351 @default.
• W3173120935 hasRelatedWork W1978015204 @default.
• W3173120935 hasRelatedWork W2023965343 @default.
• W3173120935 hasRelatedWork W2053546346 @default.
• W3173120935 hasRelatedWork W2348018984 @default.
• W3173120935 hasRelatedWork W2362580737 @default.

• next